Print

Johnson & Johnson (JNJ) Seeks Court Aid to Protect Its Glucose Monitoring Test  
9/12/2013 7:55:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

With more than 250 units making and marketing therapeutic products worldwide, Johnson & Johnson JNJ -0.03% (JNJ) is one of the most diversified global healthcare companies. And as a leader in pharmaceuticals, medical devices, and consumer personal-care products, the company not surprisingly makes sure it adequately protects its turf. Of late, its largest division, the medical device and diagnostic operations that generates some 40% of the company’s total sales, has been a focus of some of its attention.

Help employers find you! Check out all the jobs and post your resume.

//-->